1Schwinn D A. The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms. BJU Int,2001,88(suppl):27.
2Ahlquist R P. A study of the adrenotropic receptors. Am J Physiol, 1948,153:586.
3Hieble J P, Bylund D B, Clarke D E, et al. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update Pharmacol Rev. 1995,47:267.
4Lepor H, Tang R, Shapiro E. The alpha-adrenoceptor subtype mediating the tension of human prostatic smooth muscle. Prostate, 1993,22:301.
5Langer S Z. History and nomenclature of alpha1-adrenoceptors. Eur Urol, 1999,36(Suppl):2.
6Walden P D, Gerardi C, Lepor H. Localization and expression of the α1A-1-AR, α1B and α1D adrenoceptors in hyperplastic and non-hyperplastic human prostate. J Urol, 1999,161:635.
7Price D T, Schwinn D A, Lomasney J W, et al. Identification, quantification, and localization of mRNA for three distinct alpha1 adrenergic receptor subtypes in human prostate. J Urol, 1993,150:546.
8Lepor H, Tang R, Kobayashi S, et al. Localization of the α1A-adrenoceptor in the human prostate. J Urol, 1995,154: 2096.
9Malloy B J, Price D T, Price R R, et al. Alphal-adrenergic receptor subtypes in human detrusor. J Urol, 1998, 160:937.
10Hampel C, Dolber P C, Smith M P, et al. Modulation of bladder α1-adrenergic receptor subtype expression by bladder outlet obstruction.J Urol, 2002,167:1613.
4Taniguchi N,Ukai Y,Tanaka T,et al.Identification of alphal-a-drenoceptor subtypes in the human prostatic urethra[J].NaunynSchmiedebergs Arch Pharmacol.1997,355(3):412-416.
5Taniguchi N,Ukai Y,Tanaka T,et al.Identification of alpha1-a-drenoceptor subtypes in the human prostatic urethra.NaunynSchmiedebergs Arch Pharmacol.1997,355(3):412-416.
6MoritaT,Ando M,Kihata K,etal.Function and distribution of autonomic receptors in canine Ureteral Smooth muscle.N-eurouol Uordyn,1994,13:315-321.
7江海生,陈志强主编.中医临床诊治-男科专病[M].北京:人民卫生出版社,2000,74.
8Jardin A, Andersson K E, Caine M, et al. Q-blockers therapy in be- nign prostatic hyperplasia. In :3rd intema-tional consultation on be- nign prostatic hyperplasiaM3. Cockett ATK, K houry S, Asoy, et al, eds. M onaco:SCI,1995. 527- 572.
9Tubaro A, Vicentini C. Invasive and minimally invasive treatment modalities for lower urinary tract symptoms[J].EurUrol, 2000, 38(1): 7-17.
